Key Points Tilray's shares initially fell more than 12% shortly after the market opened on Tuesday. Monday's surge followed a video posted by President Trump promoting CBD for seniors, which sparked a sector-wide rally. Even after today's drop, the stock remains up sharply for the week. 10 stocks we like better than Tilray Brands › Shares of Tilray Brands (NASDAQ: TLRY) declined as much as 12.4% on Tuesday, but were down about 9% as of 10:30 a.m. ET. The pullback comes a day after a dramatic rall ...

Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare,  “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs.He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could ease criminal penalties and open broader market access.The market reacted strongly: Tilray B ...

Canopy Growth (CGC) shares soared about 18% on Monday after President Donald Trump endorsed cannabidiol (CBD) as a potential breakthrough in senior healthcare. CBD could “revolutionize senior healthcare,” Trump wrote on Truth Social over the weekend, reigniting speculation that marijuana may be reclassified under his administration. More News from Barchart Including today’s rally, Canopy Growth stock is up a little over 100% versus its year-to-date low. www.barchart.com Why Trump’s Social Media Post I ...

Monday brought some sunshine for the cannabis industry, which has otherwise seen dark clouds looming over the past few years. Cannabis shares are rallying sharply today after President Donald Trump publicly endorsed the use of cannabidiol (CBD) as a potential tool in senior healthcare. The market reaction was immediate. At the time of writing, U.S.-listed shares of Canadian cannabis players are gaining: More News from Barchart Aurora Cannabis (ACB) is up 23.6% Canopy Growth (CGC) is up 15.7% Tilray ...

Shares of cannabis stocks rallied Monday after President Donald Trump shared a video promoting putting cannabidiol, or CBD, under Medicare coverage https://t.co/eBY7utNJoD ...

Following a social media post by US President Donald Trump over the weekend, which suggested potential health benefits from cannabidiol use, shares of cannabis companies rose in early premarket tradin... ...

Group 1 - Shares of cannabis companies rose significantly in premarket trading following President Trump's social media post suggesting health benefits of cannabidiol (CBD) [1][2] - Canopy Growth and Tilray Brands saw their shares jump approximately 20%, while Cronos Group and Aurora Cannabis increased by 13.3% each [2] - The AdvisorShares Pure U.S. Cannabis ETF surged by 20.6%, on track for a record quarterly gain of around 70% [2] Group 2 - Trump's administration is considering reclassifying CBD, which could ease criminal penalties related to marijuana use [2][4] - Reclassification may eliminate the tax burden under Section 280E, allowing cannabis companies to take standard business deductions and potentially list on U.S. stock exchanges [4] - The largest U.S. marijuana-focused ETF, MSOS, is expected to rise by 20% at the open due to Trump's support for CBD [3]